Recent Developments in Imaging in BPS/IC

Overview

Journal Curr Bladder Dysfunct Rep

Publisher Springer

Date 2022 Jun 27

PMID 35756721

Authors

Teruyuki Ogawa

Pradeep Tyagi

Osamu Ishizuka

Tomohiro Ueda

Michael B Chancellor

Christopher J Chermansky

Naoki Yoshimura

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: In this review, the current literature of imaging of bladder pain syndrome and interstitial cystitis (BPS/IC) will be addressed. Topics include BPS/IC, cystoscopy, computed tomography, and magnetic resonance image (MRI).

Recent Findings: There are no randomized clinical trials on imaging of BPS/IC. Recently, contrast-enhanced MRI could detect the brain alterations and the changes in bladder permeability, and detection of the latter is enhanced by intravesical injection of contrast agents.

Summary: MRI could advance the understanding of pathological changes in the brain and the bladder of BPS/IC patients. Especially, contrast-enhanced MRI has a potential to become a diagnostic tool although more evidences are necessary for clarifying the efficacy.

References

Heinrich M, Oberbach A, Schlichting N, Stolzenburg J, Neuhaus J . Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS One. 2011; 6(6):e20792. PMC: 3107230. DOI: 10.1371/journal.pone.0020792. View

Tyagi P, Moon C, Janicki J, Kaufman J, Chancellor M, Yoshimura N . Recent advances in imaging and understanding interstitial cystitis. F1000Res. 2018; 7. PMC: 6234747. DOI: 10.12688/f1000research.16096.1. View

Chancellor M, Yoshimura N . Treatment of interstitial cystitis. Urology. 2004; 63(3 Suppl 1):85-92. DOI: 10.1016/j.urology.2003.10.034. View

Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider M . Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol. 2012; 198(6):1277-88. PMC: 6309691. DOI: 10.2214/AJR.12.8510. View

Hanno P, Burks D, Clemens J, Dmochowski R, Erickson D, Fitzgerald M . AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011; 185(6):2162-70. PMC: 9341322. DOI: 10.1016/j.juro.2011.03.064. View

Ackerman A, Lee U, Jellison F, Tan N, Patel M, Raman S . MRI suggests increased tonicity of the levator ani in women with interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2015; 27(1):77-83. DOI: 10.1007/s00192-015-2794-6. View

Ueda T, Nakagawa M, Okamura M, Tanoue H, Yoshida H, Yoshimura N . New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system. Int J Urol. 2008; 15(12):1039-43. DOI: 10.1111/j.1442-2042.2008.02179.x. View

Maeda D, Akiyama Y, Morikawa T, Kunita A, Ota Y, Katoh H . Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation. PLoS One. 2015; 10(11):e0143316. PMC: 4654580. DOI: 10.1371/journal.pone.0143316. View

Yamada Y, Nomiya A, Niimi A, Igawa Y, Ito T, Tomoe H . A survey on clinical practice of interstitial cystitis in Japan. Transl Androl Urol. 2016; 4(5):486-90. PMC: 4708551. DOI: 10.3978/j.issn.2223-4683.2015.08.06. View

10.

Whitmore K, Fall M, Sengiku A, Tomoe H, Logadottir Y, Kim Y . Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome. Int J Urol. 2019; 26 Suppl 1:26-34. DOI: 10.1111/iju.13971. View

11.

Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K . Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol. 2004; 184(1):121-7. DOI: 10.2214/ajr.184.1.01840121. View

12.

Charlanes A, Boudghene F, Chesnel C, Ciofu C, Le Breton F, Jousse M . Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis. Urol Int. 2018; 102(1):109-112. DOI: 10.1159/000493507. View

13.

Tyagi P, Janicki J, Hitchens T, Foley L, Kashyap M, Yoshimura N . Novel contrast mixture improves bladder wall contrast for visualizing bladder injury. Am J Physiol Renal Physiol. 2017; 313(2):F155-F162. PMC: 5582910. DOI: 10.1152/ajprenal.00609.2016. View

14.

Hansen C, Becker C, Montet X, Botsikas D . Diagnosis of urothelial tumors with a dedicated dual-source dual-energy MDCT protocol: preliminary results. AJR Am J Roentgenol. 2014; 202(4):W357-64. DOI: 10.2214/AJR.13.11145. View

15.

Towner R, Smith N, Saunders D, Van Gordon S, Wisniewski A, Tyler K . Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model. J Urol. 2014; 193(4):1394-400. PMC: 4706081. DOI: 10.1016/j.juro.2014.10.120. View

16.

Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T . CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis. J Urol. 2010; 183(3):1206-12. DOI: 10.1016/j.juro.2009.11.007. View

17.

Tyagi P, Janicki J, Moon C, Kaufman J, Chermansky C . Novel contrast mixture achieves contrast resolution of human bladder wall suitable for T1 mapping: applications in interstitial cystitis and beyond. Int Urol Nephrol. 2018; 50(3):401-409. PMC: 6028942. DOI: 10.1007/s11255-018-1794-0. View

18.

Coursey C, Nelson R, Boll D, Paulson E, Ho L, Neville A . Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging?. Radiographics. 2010; 30(4):1037-55. DOI: 10.1148/rg.304095175. View

19.

Lilly J, Parsons C . Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg Gynecol Obstet. 1990; 171(6):493-6. View

20.

Homma Y, Ueda T, Tomoe H, Lin A, Kuo H, Lee M . Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016; 23(7):542-9. DOI: 10.1111/iju.13118. View